Teleflex Incorporated $TFX Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH grew its position in Teleflex Incorporated (NYSE:TFX) by 227.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 27,822 shares of the medical technology company’s stock after acquiring an additional 19,327 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Teleflex were worth $3,395,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Waterfront Wealth Inc. acquired a new position in shares of Teleflex in the 4th quarter valued at about $2,050,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Teleflex by 22.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,465 shares of the medical technology company’s stock valued at $1,521,000 after purchasing an additional 2,291 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in shares of Teleflex by 90.4% in the 4th quarter. Farther Finance Advisors LLC now owns 777 shares of the medical technology company’s stock valued at $95,000 after purchasing an additional 369 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Teleflex by 1.2% during the fourth quarter. State of Alaska Department of Revenue now owns 25,138 shares of the medical technology company’s stock worth $3,067,000 after purchasing an additional 305 shares in the last quarter. Finally, V Square Quantitative Management LLC acquired a new position in shares of Teleflex during the fourth quarter worth about $37,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

TFX has been the topic of a number of recent research reports. Needham & Company LLC boosted their price objective on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Bank of America upgraded Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective on the stock in a research note on Monday, April 13th. Royal Bank Of Canada restated a “sector perform” rating on shares of Teleflex in a research note on Tuesday, April 14th. Wells Fargo & Company boosted their price objective on Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Finally, Raymond James Financial upgraded Teleflex from a “market perform” rating to an “outperform” rating and set a $128.00 price objective on the stock in a research note on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Hold” and a consensus price target of $138.50.

Teleflex Trading Down 1.7%

Shares of TFX opened at $133.16 on Thursday. The stock’s 50-day moving average is $118.49 and its two-hundred day moving average is $116.73. The stock has a market cap of $5.89 billion, a PE ratio of -6.48, a P/E/G ratio of 0.97 and a beta of 0.84. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $139.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.54 and a quick ratio of 2.01.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). The business had revenue of $569.00 million during the quarter, compared to analysts’ expectations of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company’s revenue for the quarter was down 28.5% on a year-over-year basis. During the same period in the prior year, the company posted $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts forecast that Teleflex Incorporated will post 6.77 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Friday, March 6th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is currently -6.62%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.